Susan Alpert Siegel, Ph.D.

Patent Agent« back


EDUCATION
  • Ph.D., Genetics, State University of New York, Stonybrook, 1995
  • Ph.D. candidate, Toxicology, Toxicology Program, Department of Applied Biological Sciences, Massachusetts Institute of Technology, 1993
  • B.S. with Highest Honors in Environmental Toxicology, Departmental Citation, University of California, Davis, 1982
BAR ADMISSIONS
  • U.S. Patent and Trademark Office (Reg. No. 43,121)
YEAR JOINED FIRM

1999


PRACTICE AREA OVERVIEW

Dr. Siegel prepares and prosecutes U.S., foreign, and international patent applications.

TECHNICAL EXPERTISE

Dr. Siegel has been a registered patent agent for sixteen years. She has a Ph.D. in molecular genetics, completed post-doctoral fellowships in cancer biology and immunology, and did academic research in the field of transplant rejection. She has prosecuted numerous patent applications related to monoclonal antibodies, stem cells, diagnostic assays, vaccines, anti-viral agents, adjuvants, pharmaceuticals, medical devices, cancer treatment, and therapeutics for autoimmune disease.

PRIOR PROFESSIONAL EXPERIENCE

Fish & Richardson, P.C., Menlo Park, CA
Technology Specialist

Stanford University Medical Center, Stanford, CA
Senior Research Scientist, Cardiovascular Medicine

Howard Hughes Medical Institute, Stanford University Medical Center, Stanford, CA
Post-doctoral Fellow (Irvington Institute Fellowship)

University of California, San Francisco, CA
Post-doctoral Fellow (National Institutes of Health Fellowship)

REPRESENTATIVE PATENTS
PRESENTATIONS AND PUBLICATIONS
  • “Into the Darkness: Patent Eligibility of Natural Products,” National Institutes of Health, 2014
  • “Changes in Patent Law Affecting the Biosciences Industry,” Oregon Bioscience Association, 2014
  • Opportunities and Obstacles in the Commercialization of Induced Pluripotent Stem Cells,” AUTM 2014 Annual Meeting
  • Panelist, “Commercialization of induced pluripotent stem cells,” AUTM 2013 Annual Meeting
  • “Genes, Biologics, Biomarkers…Are they patentable?” Emory University, 2012
  • Patenting Antibodies in the Shadow of Uncertainty, 4th Protein Discovery & Therapeutics Conference, 2011
  • America Invents Act and Its Effect on Patent Prosecution, University of Pittsburgh, 2011